Turtle Creek Wealth Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Turtle Creek Wealth Advisors's BIIB Position: Q2 2026 in Review
Turtle Creek Wealth Advisors increased its Biogen (BIIB) stake by 3.4% in Q2 2026, buying an estimated $10.1K and bringing the position to 1,599 shares worth $345K. The position accounts for 0.02% of the portfolio, ranked #338.
Turtle Creek Wealth Advisors first reported a position in BIIB in Q4 2023 and has held it in 4 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Turtle Creek Wealth Advisors held 1,599 shares of Biogen worth $345K as of Q2 2026.
- Turtle Creek Wealth Advisors bought 53 Biogen shares in Q2 2026, an estimated $10.1K.
- Biogen made up 0.02% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #338 holding.
- Turtle Creek Wealth Advisors first reported a position in Biogen in Q4 2023 and has held it in 4 quarters since.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.